Richard Heyman, Ph.D.

Richard Heyman, Ph.D.

Chair of the BoardatPMV Pharmaceuticals· In proxies 2023–2025

Richard Heyman, Ph.D. sits on 7 public boards.

Boards1

  • PMV PharmaceuticalsChair · 5 yr on the boardIndependentAudit, Compensation (Chair), Nominating and Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. PMV PharmaceuticalsPublic company · 3 yr
    • Chair of the Board2023 – Present · 3 yrStock in role -83%
  2. Enliven Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Pelage Pharmaceuticals, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. San DiegoPublic company
    • Director? – PresentNo stock prices for these years
  5. Amunix PharmaceuticalsPublic company
    • Director? – PresentNo stock prices for these years
  6. RayzeBio, Inc.Public company
    • Director? – PresentNo stock prices for these years
  7. Vividion TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?